[1] |
Wanebo HJ,Rao B,Pinsky CM, et al.Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.N Engl J Med, 1978, 299(9): 448-451.
|
[2] |
Takagawa R,Fujii S,Ohta M, et al.Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.Ann Surg Oncol, 2008, 15(12): 3433-3439.
|
[3] |
Park YJ,Park KJ,Park JG, et al.Prognostic factors in 2230 Korean colorectal cancer patients:analysis of consecutively operated cases.World J Surg, 1999, 23(7): 721-726.
|
[4] |
Park YJ,Youk EG,Choi HS, et al.Experience of 1446 rectal cancer patients in Korea and analysis of prognostic factors.Int J Colorectal Dis, 1999, 14(2): 101-106.
|
[5] |
Chu DZ,Erickson CA,Russell MP, et al.Prognostic significance ofcarcinoembryonic antigen in colorectal carcinoma.Serum levels before and after resection and before recurrence.Arch Surg, 1991, 126(3): 314-316.
|
[6] |
Bast R. C., Jr., Ravdin P, Hayes DF, et al.2000 update of recommendations for the use of tumor markers in breast and colorectal cancer:clinical practice guidelines of the American Society of Clinical Oncology.J Clin Oncol, 2001, 19(6): 1865-1878.
|
[7] |
Duffy MJ,van Dalen A,Haglund C, et al.Tumour markers in colorectal cancer:European Group on Tumour Markers(EGTM)guidelines for clinical use.Eur J Cancer, 2007, 43(9): 1348-1360.
|
[8] |
Duffy MJ,van Dalen A,Haglund C, et al.Clinical utility of biochemical markers in colorectal cancer:European Group on Tumour Markers(EGTM)guidelines.Eur J Cancer, 2003, 39(6): 718-727.
|
[9] |
Locker GY,Hamilton S,Harris J, et al.ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.J Clin Oncol, 2006, 24(33): 5313-5327.
|
[10] |
Morita S,Nomura T,Fukushima Y, et al.Does serum CA19-9 play a practical role in the management of patients with colorectal cancer.Dis Colon Rectum, 2004, 47(2): 227-232.
|
[11] |
Kouri M,Pyrhönen S,Kuusela P. Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma.J Surg Oncol, 1992, 49(2): 78-85.
|
[12] |
Nakagoe T,Sawai T,Tsuji T, et al.Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.Hepatogastroenterology, 2003, 50(51): 696-699.
|
[13] |
Park, I.J., Choi G.S., et al.Jun.Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer.Anticancer Res, 2009, 29(10): 4303-4308.
|
[14] |
Chen CC,Yang SH,Lin JK, et al.Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer.J Surg Res, 2005, 124(2): 169-174.
|
[15] |
Nozoe T,Rikimaru T,Mori E, et al.Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma.J Surg Oncol, 2006, 94(2): 132-137.
|
[16] |
Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer.Adopted on May 17, 1996 by the American Society of Clinical Oncology.J Clin Oncol, 1996.14(10): 2843-2877.
|